Healthcare provider profile · identity verified

Brittany Collins

Nurse Practitioner · LOWELL, MA · NPI 1548710015

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	300	37
Metoprolol Succinate	Metoprolol Succinate	193	21
Levothyroxine Sodium	Levothyroxine Sodium	189	20
Gabapentin	Gabapentin	188	23
Metformin Hcl	Metformin Hcl	155	16
Losartan Potassium	Losartan Potassium	154	13
Omeprazole	Omeprazole	152	18
Furosemide	Furosemide	148	19
Amlodipine Besylate	Amlodipine Besylate	139	17
Mirtazapine	Mirtazapine	111	13
Trazodone Hcl	Trazodone Hcl	108	25
Sertraline Hcl	Sertraline Hcl	107	12
Duloxetine Hcl	Duloxetine Hcl	87	suppressed
Tramadol Hcl	Tramadol Hcl	81	17
Torsemide	Torsemide	80	suppressed
Jardiance	Empagliflozin	75	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	73	suppressed
Simvastatin	Simvastatin	71	suppressed
Famotidine	Famotidine	69	suppressed
Lisinopril	Lisinopril	69	suppressed
Eliquis	Apixaban	68	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	61	suppressed
Levetiracetam	Levetiracetam	60	suppressed
Lorazepam	Lorazepam	55	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	48	12
Olanzapine	Olanzapine	48	suppressed
Aripiprazole	Aripiprazole	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	11
Ozempic	Semaglutide	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Clonazepam	Clonazepam	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Glipizide Er	Glipizide	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Methenamine Hippurate	Methenamine Hippurate	35	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Finasteride	Finasteride	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Retacrit	Epoetin Alfa-Epbx	29	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	29	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Paliperidone Er	Paliperidone	28	suppressed
Prazosin Hcl	Prazosin Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	26	suppressed
Buprenorphine	Buprenorphine	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Oxycontin	Oxycodone Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Linzess	Linaclotide	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Baclofen	Baclofen	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Diazepam	Diazepam	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Nystatin	Nystatin	18	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Atenolol	Atenolol	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Dilantin	Phenytoin Sodium Extended	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Glipizide	Glipizide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Olanzapine Odt	Olanzapine	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Restasis	Cyclosporine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error